The U.S. Food and Drug Administration (FDA) on Wednesday approved the emergency use of the pill against COVID-19 from the pharmaceutical company Pfizer, the first oral treatment Americans can take at home.
The FDA, a US-based drug regulatory body, said in a statement that the pill could be used to treat mild cases of corona virus in children weighing at least 40 kilograms and under 12 years of age. There is a risk of admitting them to the hospital.
Tablet Pfizer It is the first oral anticoagulant treatment that Americans can take at home, and it is expected to become an important tool against infection at a time when cases are rising from the Omigron variant.
Until now, all treatment against this disease in the United States has been administered by injection or intravenously.
The pill sold under the name PaxlovitIt can only be bought with a prescription, and patients should take it within the first five days after the onset of symptoms, once they know they have the disease.
In addition, it should be taken twice a day for about five days, the FDA described in its report.
A pill-like mechanism developed by another major pharmaceutical company, MSD (Merck in the US and Canada), works by inhibiting the activity of a specific enzyme that is required to copy the corona virus in the infected body.
The FDA is expected to approve the pill soon, however data show Pfizer It is very effective and has fewer side effects.
In particular, clinical examination Pfizer The pill has been shown to reduce mortality and hospitalization of patients at high risk of complications in 89% of cases, and its most recent data confirm that the drug is a “powerful inhibitor” against the Omigran variant.
Pfizer It said it was ready to distribute its tablets immediately and had increased its production from 80 million to 120 million by next year.
You may be interested in:
“Passionate coffee fanatic. Social media lover. Twitter expert. Extreme music practitioner. Zombie junkie. Hardcore travel specialist.”